AstraZeneca PLC (AZN) |
|
38.69 -0.06 (-0.15%)
|
04-23 16:00 |
|
Open: |
38.63 |
Pre. Close: |
38.75 |
|
High:
|
38.97 |
Low:
|
38.63 |
|
Volume:
|
4,780,624 |
Market Cap:
|
99208M |
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
39.045 - 39.267 |
39.267 - 39.508 |
|
Low:
|
37.999 - 38.248 |
38.248 - 38.519 |
|
Close:
|
38.222 - 38.653 |
38.653 - 39.122 |
|
|
|
Technical analysis |
as of: 2019-04-23 4:22:56 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 48.37 One year: 50.57 |
| Support: |
Support1: 38.35 Support2: 31.91 |
| Resistance: |
Resistance1: 41.41 Resistance2: 43.30 |
| Pivot: |
39.97  |
| Moving Average: |
MA(5): 38.86 MA(20): 40.49
MA(100): 39.33 MA(250): 38.33  |
| MACD: |
MACD(12,26): -0.71 Signal(9): -0.45 |
| Stochastic oscillator: |
%K(14,3): 11.98 %D(3): 8.59 |
| RSI: |
RSI(14): 32.23 |
| 52-week: |
High: 43.30 Low: 34.38 Change(%): 10.2 |
| Average Vol(K): |
3-Month: 528892 10-Days: 481125 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.AZN has closed above bottom band by 15.7%. Bollinger Bands are 9.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Wed, 06 Feb 2019 02:35:00 Z
AstraZeneca: Fasenra Gets FDA's ODD For Hypereosinophilic Syndrome - Quick Facts
Wed, 06 Feb 2019 02:35:00 Z
AstraZeneca: Fasenra Gets FDA's ODD For Hypereosinophilic Syndrome - Quick Facts
Tue, 05 Feb 2019 02:52:00 Z
AstraZeneca: RSV Medicine MEDI8897 Gets FDA's BTD, EMA's PRIME Eligibility
Tue, 05 Feb 2019 02:52:00 Z
AstraZeneca: RSV Medicine MEDI8897 Gets FDA's BTD, EMA's PRIME Eligibility
Fri, 25 Jan 2019 09:46:00 Z
AstraZeneca Announces Completion Of Divestment Of US Rights To Synagis
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
|
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Sector: Healthcare |
| Industry: Drug Manufacturers - Major |
| Shares Out. (M) |
2623.51 |
| Shares Float (M) |
2623.51 |
|
% Held by Insiders
|
|
|
% Held by Institutions
|
27.40 |
|
Shares Short (K)
|
16762 |
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
3.460 |
|
EPS Est. Current Year
|
1.910 |
|
EPS Est. Next Year
|
1.700 |
|
EPS Est. Next Quarter
|
0.450 |
|
Forward EPS
|
1.860 |
|
Book Value (p.s.)
|
8.560 |
|
PEG Ratio
|
1.09 |
|
Profit Margin
|
10.14 |
|
Operating Margin
|
7.92 |
|
Return on Assets (ttm)
|
3.6 |
|
Return on Equity (ttm)
|
16.2 |
|
Qtrly Rev. Growth
|
11.1 |
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
|
|
Qtrly Earnings Growth
|
-20.50 |
|
Operating Cash Flow (M)
|
2620.00 |
|
Levered Free Cash Flow (M)
|
3920.00 |
Stock Valuations |
|
P/E
|
11.18 |
|
P/E Growth Ratio
|
|
|
P/BV
|
4.52 |
|
P/S
|
5634896384.00 |
|
P/CF
|
38.74 |
Dividends & Splits |
|
Dividend
|
4.808 |
|
Dividend Yield
|
0.12 |
|
Dividend Pay Date
|
2019-03-27 |
|
Ex-Dividend Date
|
2019-02-28 |
|
Forward Dividend
|
1.400 |
|
Last Split Date
|
2015-07-27 |
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
